Adult-Onset Autosomal Recessive Sideroblastic Anemia: A Patient Guide
At a Glance
Adult-onset autosomal recessive sideroblastic anemia is a rare inherited disorder that disrupts red blood cell production and traps iron inside developing blood cells. Genetic testing, bone marrow findings, and ongoing iron monitoring help confirm the diagnosis and protect organs.
Adult-Onset Autosomal Recessive Sideroblastic Anemia is a term for a rare group of congenital (inherited) conditions that change how your body produces its most vital resource: red blood cells. While genetic conditions are often associated with childhood, this specific group of anemias frequently remains unrecognized or undiagnosed until adulthood, sometimes because the genetic variant is “milder” or because the body has found ways to compensate for years [1][2]. Receiving this diagnosis often marks the end of a long search for answers, shifting the focus from unexplained fatigue to a clear, genetically defined path forward.
At its core, this condition is a disorder of the mitochondria, the microscopic powerhouses inside your cells. In your red blood cell precursors, a genetic “roadblock” prevents iron from being incorporated efficiently into hemoglobin, the protein that carries oxygen throughout your body. Instead of being used, this iron becomes trapped and piles up inside the mitochondria. Under a microscope with a special stain, this creates a distinctive pattern of iron granules encircling the nucleus, known as ring sideroblasts [3][4]. This cellular “traffic jam” leads to ineffective red blood cell production, meaning your bone marrow works hard to create cells that are ultimately defective and cannot survive in your bloodstream.
One of the most important things to understand is that this is not a single disease, but a diverse family of genetic variants. Depending on which specific gene is affected—such as SLC25A38, GLRX5, or YARS2—the condition may be “monosyndromic,” affecting only your blood, or “syndromic,” meaning it can also impact your heart, muscles, or immune system [5][6]. Because of this complexity, confirming your exact genetic blueprint is a critical piece of the puzzle, working alongside your clinical history and bone marrow results to help distinguish this inherited condition from acquired adult disorders like Myelodysplastic Syndrome (MDS) [7][8].
Living with this condition requires a proactive approach to long-term health, particularly regarding iron overload. Because your bone marrow’s ineffective attempts to make blood send signals (like inappropriately low hepcidin) that tell your body to absorb more iron, iron can gradually build up in your liver and heart, potentially causing damage over time [9][10]. This risk exists even for patients who do not require frequent blood transfusions, though you should never start or stop iron supplements without your doctor confirming your specific levels. By working with a specialized multi-disciplinary team, you can monitor these levels and use personalized therapies to protect your organs, manage your energy, and navigate the unique challenges of this rare diagnosis with confidence.
In this guide
6 chapters
Understanding Your Diagnosis
Learn what adult-onset autosomal recessive sideroblastic anemia means, why it can be diagnosed later, and how genes, iron overload, and care fit together.
Biology & Differential Diagnosis
Learn how adult-onset autosomal recessive sideroblastic anemia causes ring sideroblasts and how genetic testing distinguishes it from MDS and acquired causes.
Genotypes, Syndromes & Multi-Organ Health
Learn how gene variants shape adult-onset autosomal recessive sideroblastic anemia, including syndromes, organ risks, screening, and key care team questions.
Standard of Care & Treatment Pathways
Learn how adult-onset autosomal recessive sideroblastic anemia is treated, including transfusions, B6 trials, iron monitoring, chelation, and transplant risks.
Monitoring & Living with Your Condition
Learn to monitor adult-onset autosomal recessive sideroblastic anemia, manage fatigue, track iron burden, and recognize urgent warning signs for daily care.
Building Your Care Team & Understanding Your Reports
Learn how to build a care team for adult-onset autosomal recessive sideroblastic anemia and understand bone marrow, genetic, and somatic test reports clearly.
Common questions in this guide
What is adult-onset autosomal recessive sideroblastic anemia?
How do doctors tell whether this anemia is inherited or acquired?
What are ring sideroblasts, and why do they matter?
Can iron overload occur even if I do not get regular blood transfusions?
Could my specific gene change affect organs besides my blood?
Which specialists should be involved in my care?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my specific genetic mutation primarily affect my blood production, or should we be monitoring other organ systems like my heart or muscles?
- 2.How can we use my clinical history, bone marrow, and genetic testing together to be certain this is an inherited condition rather than an acquired disorder like MDS?
- 3.What is our plan for monitoring my iron levels, and at what point would we need to start treatment to protect my organs?
- 4.Given the rarity of this condition, how can we ensure my care is coordinated between my hematologist and any other necessary specialists?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (10)
- 1
The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2.
Riley LG, Heeney MM, Rudinger-Thirion J, et al.
Haematologica 2018; (103(12)):2008-2015 doi:10.3324/haematol.2017.182659.
PMID: 30026338 - 2
Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
Cazzola M, Malcovati L
Hematology. American Society of Hematology. Education Program 2015; (2015()):19-25 doi:10.1182/asheducation-2015.1.19.
PMID: 26637696 - 3
Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia.
Lunetti P, Damiano F, De Benedetto G, et al.
The Journal of biological chemistry 2016; (291(38)):19746-59 doi:10.1074/jbc.M116.736876.
PMID: 27476175 - 4
Causes and Pathophysiology of Acquired Sideroblastic Anemia.
Rodriguez-Sevilla JJ, Calvo X, Arenillas L
Genes 2022; (13(9)) doi:10.3390/genes13091562.
PMID: 36140729 - 5
Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.
Uminski K, Houston DS, Hartley JN, et al.
Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.
PMID: 32790119 - 6
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.
Sommerville EW, Ng YS, Alston CL, et al.
JAMA neurology 2017; (74(6)):686-694 doi:10.1001/jamaneurol.2016.4357.
PMID: 28395030 - 7
Sideroblastic anemia in children: challenges in diagnosis and management in three cases.
Rekaya S, Ben Fraj I, Hamdi R, et al.
Annals of hematology 2025; (104(4)):2537-2543 doi:10.1007/s00277-025-06266-5.
PMID: 40042629 - 8
Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options.
Abu-Zeinah G, DeSancho MT
Journal of blood medicine 2020; (11()):305-318 doi:10.2147/JBM.S232644.
PMID: 33061728 - 9
Differentiating iron-loading anemias using a newly developed and analytically validated ELISA for human serum erythroferrone.
Diepeveen L, Roelofs R, Grebenchtchikov N, et al.
PloS one 2021; (16(7)):e0254851 doi:10.1371/journal.pone.0254851.
PMID: 34283879 - 10
Pathophysiology and classification of iron overload diseases; update 2018.
Brissot P, Troadec MB, Loréal O, Brissot E
Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2019; (26(1)):80-88 doi:10.1016/j.tracli.2018.08.006.
PMID: 30173950
This page is for informational purposes only and does not constitute medical advice. A hematologist and genetics team should interpret your genetic, bone marrow, and iron results and guide your care.
Get notified when new evidence is published on Adult-onset autosomal recessive sideroblastic anemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.